$KERX Headlines When it rains, it pours for Na
Post# of 72709
Posted On: 06/24/2014 10:41:17 AM
$KERX Headlines
When it rains, it pours for Nasdaq leadership 12:47 p.m. March 27, 2014 - The Trading Deck
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
Nasdaq extends break to less-charted territory 12:42 p.m. Dec. 2, 2013 - Michael Ashbaugh
6 movers to watch 3:08 p.m. Nov. 6, 2013 - The Trading Deck
Keryx climbs after treatment shows positive result 11:01 a.m. Nov. 5, 2013 - MarketWatch.com
Six stocks to watch for some upside 3:21 p.m. April 11, 2013 - The Trading Deck
6 gut checks before the stock market's opening bell 7:47 a.m. March 7, 2013 - Shawn Langlois
Towerstream, Vanguard and others price offerings 11:32 a.m. Jan. 31, 2013 - MarketWatch.com
6 gut checks before the stock market's opening bell 7:52 a.m. Jan. 31, 2013 - Shawn Langlois
Keryx Biopharmaceuticals up 8.5% in premarket 8:58 a.m. Jan. 29, 2013 - Steve Gelsi
Monday’s movers: Herbalife clobbered on FTC news 5:30 p.m. Jan. 28, 2013 - Sue Chang
In focus: No letup by the bulls 8:45 p.m. Jan. 23, 2013 - Lawrence G. McMillan
Keryx Biopharma rises 17% in premarket trades 8:36 a.m. Jan. 23, 2013 - Steve Gelsi
Monday’s biggest gaining and declining stocks 4:37 p.m. April 23, 2012 - MarketWatch
Monday’s biggest gaining & declining stocks 5:56 p.m. April 2, 2012 - Kate Gibson
Keryx, AEterna implode on failed drug study 11:13 a.m. April 2, 2012 - Val Brickates Kennedy
Keryx, AEterna rally ahead of study results 1:34 p.m. March 16, 2012 - Val Brickates Kennedy
Keryx , AEterna rally ahead of study results 1:32 p.m. March 16, 2012 - Val Brickates Kennedy
Top longs and shorts to watch 1:18 p.m. March 6, 2012 - The Trading Deck
AEterna, Keryx soar on study speculation 1:52 p.m. March 5, 2012 - Val Brickates Kennedy
Keryx Biopharmaceuticals: Baupost Group's New Position Suggests A Possible Takeout And 100%+ Gains 8:00 a.m. Today - Seeking Alpha
Two new patents for Zerenex 9:55 a.m. June 18, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ACOR SHPG WX ACT 6:45 a.m. June 18, 2014 - InvestorPlace.com
Keryx Biopharmaceuticals ' Management Presents at 35th Annual Goldman Sachs Global Healthcare Conference (Transcript) 4:45 p.m. June 12, 2014 - Seeking Alpha
Building a Biotech Basket 5:00 p.m. June 11, 2014 - RealMoney.com
Hottest Healthcare Stocks Now – EXAS MNKD KERX MYGN 8:00 a.m. June 4, 2014 - InvestorPlace.com
Keryx Biopharma: Approval Delay Does Not Change Zerenex Prospects Or Differentiation 7:34 p.m. May 29, 2014 - Seeking Alpha
Keryx PDUFA extension creates buying opportunity, Oppenheimer says 10:32 a.m. May 23, 2014 - Seeking Alpha
Trade-Ideas: Keryx Biopharmaceuticals (KERX) Is Today's Pre-Market Mover With Heavy Volume Stock 9:02 a.m. May 23, 2014 - TheStreet.com
Keryx -4.9% AH; FDA extends goal date for Zerenex review 5:36 p.m. May 22, 2014 - Seeking Alpha
Keryx Ferric Citrate (Zerenex) Could Potentially Save Hemodialysis Patients $1B Annually 1:24 p.m. May 22, 2014 - Seeking Alpha
Seth Klarman's Baupost: Investment Changes During The First Quarter 11:40 a.m. May 19, 2014 - Seeking Alpha
Seth Klarman Buys Cheniere Energy, Keryx Biopharmaceuticals, Idenix Pharmaceuticals, Sells BP, ... 5:20 p.m. May 15, 2014 - GuruFocus.com
Tracking Seth Klarman's Baupost Group Holdings - Q1 2014 Update 4:18 a.m. May 15, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – HALO BKD ESC MCK 7:15 a.m. May 13, 2014 - InvestorPlace.com
Baupost's Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals 5:43 p.m. May 12, 2014 - GuruFocus.com
My Favorite Investing Week 11:30 a.m. May 12, 2014 - RealMoney.com
2014 FDA Drug Approval Calendar 9:22 a.m. May 12, 2014 - TheStreet.com
UPDATE: MLV & Co Reiterates On Keryx Biopharmaceuticals On Increased Risk 7:12 a.m. May 12, 2014 - benzinga.com
10-Q: KERYX BIOPHARMACEUTICALS INC 4:10 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate 8:31 a.m. June 18, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate 8:31 a.m. June 18, 2014 - Thomson Reuters ONE
Keryx Biopharmaceuticals, Inc. to Present at the 9th Annual JMP Securities Healthcare Conference 4:30 p.m. June 17, 2014 - GlobeNewswire
Trial Results, Patient Enrollment, and Strategic Collaborations - Analyst Notes on Alnylam, Celldex, Keryx, Spectrum and MacroGenics 5:20 a.m. June 12, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals, Inc. to Present at the 35th Annual Goldman Sachs Global Healthcare Conference 8:33 a.m. June 5, 2014 - GlobeNewswire
Pre-Market Review on Biotechnology Equities -- Research on BioMarin Pharma, Keryx Biopharma, Amgen, and Peregrine Pharma 8:30 a.m. May 30, 2014 - PR Newswire - PRF
Annual Meetings, Clinical Data Presentation, Acquisitions, Agreements, and Date Extensions - Analyst Notes on Omnicare, Auxilium, Covance, Ophthotech and Keryx 7:30 a.m. May 27, 2014 - PR Newswire - PRF
Keryx Receives Notification of PDUFA Date Extension for Zerenex(TM) 4:31 p.m. May 22, 2014 - GlobeNewswire
Upcoming Analyst Meetings, New Products, Collaborations, and Awards - Analyst Notes on Thermo Fisher Scientific, Agilent, United Therapeutics, Keryx and Centene 1:26 p.m. May 16, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2014 Financial Results 7:01 a.m. May 8, 2014 - Thomson Reuters ONE
Pre-market Biotech Picks -- Research on Dendreon, Keryx Biopharma, Idera Pharma, and Vertex Pharma 8:00 a.m. May 7, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals Announces Opening of Boston Office 8:01 a.m. May 6, 2014 - GlobeNewswire
Keryx Biopharmaceuticals, Inc. to Host Conference Call on First Quarter 2014 Financial Results 4:40 p.m. May 5, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Strengthens Leadership Team With Key Additions in Sales, Corporate Development and Legal 8:31 a.m. April 15, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Strengthens Leadership Team With Key Additions in Sales, Corporate Development and Legal 8:31 a.m. April 15, 2014 - Thomson Reuters ONE
Keryx Biopharmaceuticals Announces Zerenex(TM) (Ferric Citrate Coordination Complex) Phase 2 Results in Non-Dialysis Dependent Chronic Kidney Disease Selected as a Late Breaking Oral Presentation at the Upcoming National Kidney Foundation 2014 Spring Clinical Meeting 8:31 a.m. April 9, 2014 - GlobeNewswire
GlobeNewswire Press Release: Keryx Biopharmaceuticals, Inc. 8:31 a.m. April 9, 2014 - Thomson Reuters ONE
Health Care Sector Stocks under Review -- Research on Sanofi, Impax Laboratories, Keryx Biopharma, and Rigel Pharma 1:59 p.m. April 8, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex(TM) 9:43 a.m. April 2, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex(TM) 8:31 a.m. April 2, 2014 - Thomson Reuters ONE
When it rains, it pours for Nasdaq leadership 12:47 p.m. March 27, 2014 - The Trading Deck
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
Nasdaq extends break to less-charted territory 12:42 p.m. Dec. 2, 2013 - Michael Ashbaugh
6 movers to watch 3:08 p.m. Nov. 6, 2013 - The Trading Deck
Keryx climbs after treatment shows positive result 11:01 a.m. Nov. 5, 2013 - MarketWatch.com
Six stocks to watch for some upside 3:21 p.m. April 11, 2013 - The Trading Deck
6 gut checks before the stock market's opening bell 7:47 a.m. March 7, 2013 - Shawn Langlois
Towerstream, Vanguard and others price offerings 11:32 a.m. Jan. 31, 2013 - MarketWatch.com
6 gut checks before the stock market's opening bell 7:52 a.m. Jan. 31, 2013 - Shawn Langlois
Keryx Biopharmaceuticals up 8.5% in premarket 8:58 a.m. Jan. 29, 2013 - Steve Gelsi
Monday’s movers: Herbalife clobbered on FTC news 5:30 p.m. Jan. 28, 2013 - Sue Chang
In focus: No letup by the bulls 8:45 p.m. Jan. 23, 2013 - Lawrence G. McMillan
Keryx Biopharma rises 17% in premarket trades 8:36 a.m. Jan. 23, 2013 - Steve Gelsi
Monday’s biggest gaining and declining stocks 4:37 p.m. April 23, 2012 - MarketWatch
Monday’s biggest gaining & declining stocks 5:56 p.m. April 2, 2012 - Kate Gibson
Keryx, AEterna implode on failed drug study 11:13 a.m. April 2, 2012 - Val Brickates Kennedy
Keryx, AEterna rally ahead of study results 1:34 p.m. March 16, 2012 - Val Brickates Kennedy
Keryx , AEterna rally ahead of study results 1:32 p.m. March 16, 2012 - Val Brickates Kennedy
Top longs and shorts to watch 1:18 p.m. March 6, 2012 - The Trading Deck
AEterna, Keryx soar on study speculation 1:52 p.m. March 5, 2012 - Val Brickates Kennedy
Keryx Biopharmaceuticals: Baupost Group's New Position Suggests A Possible Takeout And 100%+ Gains 8:00 a.m. Today - Seeking Alpha
Two new patents for Zerenex 9:55 a.m. June 18, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ACOR SHPG WX ACT 6:45 a.m. June 18, 2014 - InvestorPlace.com
Keryx Biopharmaceuticals ' Management Presents at 35th Annual Goldman Sachs Global Healthcare Conference (Transcript) 4:45 p.m. June 12, 2014 - Seeking Alpha
Building a Biotech Basket 5:00 p.m. June 11, 2014 - RealMoney.com
Hottest Healthcare Stocks Now – EXAS MNKD KERX MYGN 8:00 a.m. June 4, 2014 - InvestorPlace.com
Keryx Biopharma: Approval Delay Does Not Change Zerenex Prospects Or Differentiation 7:34 p.m. May 29, 2014 - Seeking Alpha
Keryx PDUFA extension creates buying opportunity, Oppenheimer says 10:32 a.m. May 23, 2014 - Seeking Alpha
Trade-Ideas: Keryx Biopharmaceuticals (KERX) Is Today's Pre-Market Mover With Heavy Volume Stock 9:02 a.m. May 23, 2014 - TheStreet.com
Keryx -4.9% AH; FDA extends goal date for Zerenex review 5:36 p.m. May 22, 2014 - Seeking Alpha
Keryx Ferric Citrate (Zerenex) Could Potentially Save Hemodialysis Patients $1B Annually 1:24 p.m. May 22, 2014 - Seeking Alpha
Seth Klarman's Baupost: Investment Changes During The First Quarter 11:40 a.m. May 19, 2014 - Seeking Alpha
Seth Klarman Buys Cheniere Energy, Keryx Biopharmaceuticals, Idenix Pharmaceuticals, Sells BP, ... 5:20 p.m. May 15, 2014 - GuruFocus.com
Tracking Seth Klarman's Baupost Group Holdings - Q1 2014 Update 4:18 a.m. May 15, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – HALO BKD ESC MCK 7:15 a.m. May 13, 2014 - InvestorPlace.com
Baupost's Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals 5:43 p.m. May 12, 2014 - GuruFocus.com
My Favorite Investing Week 11:30 a.m. May 12, 2014 - RealMoney.com
2014 FDA Drug Approval Calendar 9:22 a.m. May 12, 2014 - TheStreet.com
UPDATE: MLV & Co Reiterates On Keryx Biopharmaceuticals On Increased Risk 7:12 a.m. May 12, 2014 - benzinga.com
10-Q: KERYX BIOPHARMACEUTICALS INC 4:10 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate 8:31 a.m. June 18, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate 8:31 a.m. June 18, 2014 - Thomson Reuters ONE
Keryx Biopharmaceuticals, Inc. to Present at the 9th Annual JMP Securities Healthcare Conference 4:30 p.m. June 17, 2014 - GlobeNewswire
Trial Results, Patient Enrollment, and Strategic Collaborations - Analyst Notes on Alnylam, Celldex, Keryx, Spectrum and MacroGenics 5:20 a.m. June 12, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals, Inc. to Present at the 35th Annual Goldman Sachs Global Healthcare Conference 8:33 a.m. June 5, 2014 - GlobeNewswire
Pre-Market Review on Biotechnology Equities -- Research on BioMarin Pharma, Keryx Biopharma, Amgen, and Peregrine Pharma 8:30 a.m. May 30, 2014 - PR Newswire - PRF
Annual Meetings, Clinical Data Presentation, Acquisitions, Agreements, and Date Extensions - Analyst Notes on Omnicare, Auxilium, Covance, Ophthotech and Keryx 7:30 a.m. May 27, 2014 - PR Newswire - PRF
Keryx Receives Notification of PDUFA Date Extension for Zerenex(TM) 4:31 p.m. May 22, 2014 - GlobeNewswire
Upcoming Analyst Meetings, New Products, Collaborations, and Awards - Analyst Notes on Thermo Fisher Scientific, Agilent, United Therapeutics, Keryx and Centene 1:26 p.m. May 16, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2014 Financial Results 7:01 a.m. May 8, 2014 - Thomson Reuters ONE
Pre-market Biotech Picks -- Research on Dendreon, Keryx Biopharma, Idera Pharma, and Vertex Pharma 8:00 a.m. May 7, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals Announces Opening of Boston Office 8:01 a.m. May 6, 2014 - GlobeNewswire
Keryx Biopharmaceuticals, Inc. to Host Conference Call on First Quarter 2014 Financial Results 4:40 p.m. May 5, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Strengthens Leadership Team With Key Additions in Sales, Corporate Development and Legal 8:31 a.m. April 15, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Strengthens Leadership Team With Key Additions in Sales, Corporate Development and Legal 8:31 a.m. April 15, 2014 - Thomson Reuters ONE
Keryx Biopharmaceuticals Announces Zerenex(TM) (Ferric Citrate Coordination Complex) Phase 2 Results in Non-Dialysis Dependent Chronic Kidney Disease Selected as a Late Breaking Oral Presentation at the Upcoming National Kidney Foundation 2014 Spring Clinical Meeting 8:31 a.m. April 9, 2014 - GlobeNewswire
GlobeNewswire Press Release: Keryx Biopharmaceuticals, Inc. 8:31 a.m. April 9, 2014 - Thomson Reuters ONE
Health Care Sector Stocks under Review -- Research on Sanofi, Impax Laboratories, Keryx Biopharma, and Rigel Pharma 1:59 p.m. April 8, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex(TM) 9:43 a.m. April 2, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex(TM) 8:31 a.m. April 2, 2014 - Thomson Reuters ONE
(0)
(0)Scroll down for more posts ▼